Lomond Therapeutics Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lomond Therapeutics Holdings, Inc. annual/quarterly Operating Income (Loss) history and growth rate from Q4 2021 to Q3 2024.
  • Lomond Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11K, a 0.76% decline year-over-year.
  • Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$16.3M.
  • Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$9.75M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$11K -$83 -0.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-28
Q2 2024 -$11.5K +$1.36K +10.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$11.3K +$1.84K +14% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 -$46.5K -$10.9K +$5.72K +34.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-28
Q2 2023 -$52.2K -$12.8K +$204 +1.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$52.4K -$13.1K -$3.56K -37.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$48.9K -$9.69K -$3.77K -63.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$45.1K -$16.6K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$13K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9.57K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$5.91K Sep 24, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.